arrow
A

Andrew H. Baker

Maastricht University Medical Center
H指数:84
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Atherosclerotic plaque fibroblasts derive from adventitial and medial Pdgfra-lineage-positive cells and predominantly maintain fibroblast identity

动脉粥样硬化斑块成纤维细胞来源于外膜和中膜Pdgfra谱系阳性细胞,并主要维持成纤维细胞表型

2026-09-090
OAAI
LINC00607 facilitates endothelial VEGF-A receptor FLT1 splicing

LINC00607促进内皮细胞VEGF-A受体FLT1的剪接

2026-04-040
OAAI
Small Interfering RNA Therapy Targeting the Long Noncoding RNA SMILR for Therapeutic Intervention in Coronary Artery Bypass Graft Failure

靶向长链非编码RNA SMILR的小干扰RNA疗法,用于冠状动脉旁路移植术失败的 therapeutic intervention

2025-09-100
OAAI
Gene therapy in cardiac and vascular diseases: a review of approaches to treat genetic and common cardiovascular diseases with novel gene-based therapeutics

Musolino, P.L.; Rosser, S.J.; Brittan, M.; Newby, D.E.; Berry, C.; Riley, P.R.; Giacca, M.; Hajjar, R.J.; Baker, A.H. 心脏和血管疾病中的基因治疗:对采用新型基因治疗药物治疗遗传性和常见心血管疾病的方法的综述。Cardiovasc. Res. 2025, cvaf109. [Google Scholar] [CrossRef] [PubMed]

2025-08-011
OA
The loss of microRNA-26b promotes aortic calcification through the regulation of cell-specific target genes

微RNA-26b的丢失通过调控细胞特异性靶基因促进主动脉钙化。

2025-07-010
OAAI
Long noncoding RNAs and machine learning to improve cardiovascular outcomes of COVID-19

长链非编码RNA与机器学习在改善COVID-19心血管结局中的应用

2024-11-120
PRE
Prediction of COVID-19 severity using machine learning
2024-10-060
OAAI